2022年欧洲新生儿呼吸窘迫综合征管理指南更新要点解读

林梅; 张雪; 王亚云; 朱晓波; 薛江

doi:10.7499/j.issn.1008-8830.2303046

PDF(522 KB)

HTML

中国当代儿科杂志 ›› 2023, Vol. 25 ›› Issue (8) : 779-784. DOI: 10.7499/j.issn.1008-8830.2303046

指南解读

2022年欧洲新生儿呼吸窘迫综合征管理指南更新要点解读

林梅, 张雪, 王亚云, 朱晓波, 薛江

作者信息 +

Interpretation of the key updates in the 2022 European guideline on the management of neonatal respiratory distress syndrome

LIN Mei, ZHANG Xue, WANG Ya-Yun, ZHU Xiao-Bo, XUE Jiang

Author information +

文章历史 +

摘要

随着临床研究的深入，新生儿呼吸窘迫综合征（respiratory distress syndrome，RDS）的管理需优化和改进。该文旨在介绍2022年欧洲新生儿RDS管理指南，重点介绍其更新要点。该指南对早产风险预测、产妇转诊、产前糖皮质激素的应用、肺保护性通气策略的应用，以及RDS患儿的一般护理等方面的管理进行了优化。该指南主要适用于胎龄>24周新生儿RDS的管理。

Abstract

With the deepening of clinical research, the management of neonatal respiratory distress syndrome (RDS) needs to be optimized and improved. This article aims to introduce the 2022 European guideline on the management of neonatal RDS, focusing on its key updates. The guide has optimized the management of risk prediction for preterm birth, maternal referral, application of prenatal corticosteroids, application of lung protective ventilation strategies, and general care for infants with RDS. The guideline is mainly applicable to the management of RDS in neonates with gestational age greater than 24 weeks.

导出引用

林梅, 张雪, 王亚云, 朱晓波, 薛江. 2022年欧洲新生儿呼吸窘迫综合征管理指南更新要点解读[J]. 中国当代儿科杂志. 2023, 25(8): 779-784 https://doi.org/10.7499/j.issn.1008-8830.2303046

LIN Mei, ZHANG Xue, WANG Ya-Yun, ZHU Xiao-Bo, XUE Jiang. Interpretation of the key updates in the 2022 European guideline on the management of neonatal respiratory distress syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2023, 25(8): 779-784 https://doi.org/10.7499/j.issn.1008-8830.2303046

参考文献

1 Haumont D, Modi N, Saugstad OD, et al. Evaluating preterm care across Europe using the eNewborn European Network database[J]. Pediatr Res, 2020, 88(3): 484-495. PMID: 31972855. DOI: 10.1038/s41390-020-0769-x.
2 Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome[J]. J Perinat Med, 2007, 35(3): 175-186. PMID: 17480144. DOI: 10.1515/JPM.2007.048.
3 Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2010 update[J]. Neonatology, 2010, 97(4): 402-417. PMID: 20551710. DOI: 10.1159/000297773.
4 Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2019 update[J]. Neonatology, 2019, 115(4): 432-450. PMID: 30974433. PMCID: PMC6604659. DOI: 10.1159/000499361.
5 Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2016 update[J]. Neonatology, 2017, 111(2): 107-125. PMID: 27649091. DOI: 10.1159/000448985.
6 Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2013 update[J]. Neonatology, 2013, 103(4): 353-368. PMID: 23736015. DOI: 10.1159/000349928.
7 Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update[J]. Neonatology, 2023, 120(1): 3-23. PMID: 36863329. PMCID: PMC10064400. DOI: 10.1159/000528914.
8 Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[J]. Cochrane Database Syst Rev, 2019, 2019(10): CD004659. PMID: 31684684. PMCID: PMC6820858. DOI: 10.1002/14651858.CD004659.pub3.
9 EPPPIC Group. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials[J]. Lancet, 2021, 397(10280): 1183-1194. PMID: 33773630. DOI: 10.1016/S0140-6736(21)00217-8.
10 Melchor JC, Khalil A, Wing D, et al. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2018, 52(4): 442-451. PMID: 29920825. DOI: 10.1002/uog.19119.
11 Daskalakis G, Pergialiotis V, Domell?f M, et al. European guidelines on perinatal care: corticosteroids for women at risk of preterm birth[J]. J Matern Fetal Neonatal Med, 2023, 36(1): 2160628. PMID: 36689999. DOI: 10.1080/14767058.2022.2160628.
12 Ehret DEY, Edwards EM, Greenberg LT, et al. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks' gestation[J]. JAMA Netw Open, 2018, 1(6): e183235. PMID: 30646235. PMCID: PMC6324435. DOI: 10.1001/jamanetworkopen.2018.3235.
13 R?ikk?nen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children[J]. JAMA, 2020, 323(19): 1924-1933. PMID: 32427304. PMCID: PMC7237984. DOI: 10.1001/jama.2020.3937.
14 McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth[J]. Cochrane Database Syst Rev, 2020, 12(12): CD004454. PMID: 33368142. PMCID: PMC8094626. DOI: 10.1002/14651858.CD004454.pub4.
15 中国医师协会新生儿科医师分会, 《中华围产医学杂志》编辑委员会. 早产儿呼吸窘迫综合征早期防治专家共识[J]. 中华围产医学杂志, 2017, 20(8): 557-559. DOI: 10.3760/cma.j.issn.1007-9408.2017.08.002.
16 Jasani B, Torgalkar R, Ye XY, et al. Association of umbilical cord management strategies with outcomes of preterm infants: a systematic review and network meta-analysis[J]. JAMA Pediatr, 2021, 175(4): e210102. PMID: 33683307. PMCID: PMC7941254. DOI: 10.1001/jamapediatrics.2021.0102.
17 中国医师协会新生儿科医师分会, 中国妇幼保健协会新生儿保健专业委员会, 《发育医学电子杂志》编辑委员会. 胎盘输血专家共识[J]. 发育医学电子杂志, 2021, 9(4): 241-247. DOI: 10.3969/j.issn.2095-5340.2021.04.001.
18 Subramaniam P, Ho JJ, Davis PG. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants[J]. Cochrane Database Syst Rev, 2021, 10(10): CD001243. PMID: 34661278. PMCID: PMC8521644. DOI: 10.1002/14651858.CD001243.pub4.
19 中国新生儿复苏项目专家组, 中华医学会围产医学分会新生儿复苏学组. 中国新生儿复苏指南（2021年修订）[J]. 中华围产医学杂志, 2022, 25(1): 4-12. DOI: 10.3760/cma.j.cn113903-20211122-00967.
20 中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会. 中国新生儿肺表面活性物质临床应用专家共识（2021版）[J]. 中华儿科杂志, 2021, 59(8): 627-632. PMID: 34333913. DOI: 10.3760/cma.j.cn112140-20210329-00261.
21 Abdel-Latif ME, Davis PG, Wheeler KI, et al. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome[J]. Cochrane Database Syst Rev, 2021, 5(5): CD011672. PMID: 33970483. PMCID: PMC8109227. DOI: 10.1002/14651858.CD011672.pub2.
22 Reynolds P, Bustani P, Darby C, et al. Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline[J]. Neonatology, 2021, 118(5): 586-592. PMID: 34515188. DOI: 10.1159/000518396.
23 Roberts KD, Brown R, Lampland AL, et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial[J]. J Pediatr, 2018, 193: 40-46.e1. PMID: 29174079. DOI: 10.1016/j.jpeds.2017.09.068.
24 亚太卫生健康协会儿科医学分会, 亚太卫生健康协会儿科医学分会重症超声医学专业委员会, 世界重症超声联盟中国联盟, 等. 新生儿呼吸窘迫综合征超声诊断与分度专家共识[J]. 中国小儿急救医学, 2021, 28(7): 545-551. DOI: 10.3760/cma.j.issn.1673-4912.2021.07.001.
25 Capasso L, Pacella D, Migliaro F, et al. Can lung ultrasound score accurately predict the need for surfactant replacement in preterm neonates? A systematic review and meta-analysis protocol[J]. PLoS One, 2021, 16(7): e0255332. PMID: 34320032. PMCID: PMC8318286. DOI: 10.1371/journal.pone.0255332.
26 Liu T, Tomlinson LA, Yu Y, et al. Changes in institutional oxygen saturation targets are associated with an increased rate of severe retinopathy of prematurity[J]. J AAPOS, 2022, 26(1): 18.e1-18.e6. PMID: 35032651. DOI: 10.1016/j.jaapos.2021.10.002.
27 Ramaswamy VV, More K, Roehr CC, et al. Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: systematic review and network meta-analysis[J]. Pediatr Pulmonol, 2020, 55(11): 2940-2963. PMID: 32762014. DOI: 10.1002/ppul.25011.
28 Ramaswamy VV, Bandyopadhyay T, Nanda D, et al. Efficacy of noninvasive respiratory support modes as postextubation respiratory support in preterm neonates: a systematic review and network meta-analysis[J]. Pediatr Pulmonol, 2020, 55(11): 2924-2939. PMID: 32757365. DOI: 10.1002/ppul.25007.
29 Li J, Chen L, Shi Y. Nasal high-frequency oscillatory ventilation versus nasal continuous positive airway pressure as primary respiratory support strategies for respiratory distress syndrome in preterm infants: a systematic review and meta-analysis[J]. Eur J Pediatr, 2022, 181(1): 215-223. PMID: 34254173. DOI: 10.1007/s00431-021-04190-0.
30 Bassler D, Shinwell ES, Hallman M, et al. Long-term effects of inhaled budesonide for bronchopulmonary dysplasia[J]. N Engl J Med, 2018, 378(2): 148-157. PMID: 29320647. DOI: 10.1056/NEJMoa1708831.
31 Garrido F, Gonzalez-Caballero JL, Lomax R, et al. The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport[J]. Acta Paediatr, 2020, 109(2): 309-313. PMID: 31373038. DOI: 10.1111/apa.14958.
32 国家儿童健康与疾病临床医学研究中心/儿童发育疾病研究教育部重点实验室/儿科学重庆市重点实验室/重庆医科大学附属儿童医院. 中国新生儿疼痛管理循证指南（2023年）[J]. 中国当代儿科杂志, 2023, 25(2): 109-127. PMID: 36854686. PMCID: PMC9979385. DOI: 10.7499/j.issn.1008-8830.2210052.
33 Ray S. Nice guideline review: neonatal parenteral nutrition (NG154)[J]. Arch Dis Child Educ Pract Ed, 2021, 106(5): 292-295. PMID: 33199498. DOI: 10.1136/archdischild-2020-320581.
34 Jochum F, Moltu SJ, Senterre T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: fluid and electrolytes[J]. Clin Nutr, 2018, 37(6 Pt B): 2344-2353. PMID: 30064846. DOI: 10.1016/j.clnu.2018.06.948.
35 Capin I, Hinds A, Vomero B, et al. Are early-onset sepsis evaluations and empiric antibiotics mandatory for all neonates admitted with respiratory distress?[J]. Am J Perinatol, 2022, 39(4): 444-448. PMID: 32947642. DOI: 10.1055/s-0040-1717070.
36 Nestaas E. Neonatologist performed echocardiography for evaluating the newborn infant[J]. Front Pediatr, 2022, 10: 853205. PMID: 35402362. PMCID: PMC8987714. DOI: 10.3389/fped.2022.853205.
37 Rozé JC, Cambonie G, Marchand-Martin L, et al. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants[J]. JAMA, 2015, 313(24): 2441-2448. PMID: 26103028. DOI: 10.1001/jama.2015.6734.
38 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 743-745.
39 Mohamed MA, El-Dib M, Alqahtani S, et al. Patent ductus arteriosus in premature infants: to treat or not to treat?[J]. J Perinatol, 2017, 37(6): 652-657. PMID: 28206995. DOI: 10.1038/jp.2017.4.
40 Bell EF. Red cell transfusion thresholds for preterm infants: finally some answers[J]. Arch Dis Child Fetal Neonatal Ed, 2022, 107(2): 126-130. PMID: 33906941. DOI: 10.1136/archdischild-2020-320495.